VEGFA and small cell lung carcinoma: Regarding overall perspective of advanced SCLC, Allen and colleagues reported on a phase II trial of weekly topotecan with and without ziv-aflibercept, a VEGF-trapping agent, in patients with advanced platinum-treated small-cell lung cancer [4].